Oxfordshire, United Kingdom

Andrew Brearley

USPTO Granted Patents = 3 


Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: **The Innovations of Andrew Brearley: A Patent Contributor from Oxfordshire**

Introduction

Andrew Brearley, an inventive mind hailing from Oxfordshire, GB, has made significant contributions to the field of pharmaceuticals through his innovative works. With a total of three patents to his name, Brearley has demonstrated a commitment to advancing therapeutic solutions.

Latest Patents

Brearley's latest patents focus on carboxamide derivatives, featuring compounds that possess unique pharmacological properties. The patents provide a method for manufacturing these compounds, alongside detailed descriptions of their therapeutic uses. Notably, the invention includes a combination of pharmacologically active agents and a pharmaceutical composition, aiming to enhance treatment efficacy.

Career Highlights

Currently working at Novartis AG, a leading global healthcare company, Brearley continues to refine his innovative approaches in drug development. His contributions have played a crucial role in the research and development of novel therapeutic agents.

Collaborations

Throughout his career, Andrew Brearley has collaborated with notable colleagues such as Kamlesh Jagdis Bala and James Dale. These partnerships highlight the collaborative spirit prevalent in the field of pharmaceutical research, fostering an environment where innovative ideas can flourish.

Conclusion

Andrew Brearley's work exemplifies the impact of innovation in the pharmaceutical industry. Through his patents and collaborative efforts, he is helping to shape a future where more effective therapies can be made available to patients worldwide. His journey underscores the importance of inventive thinking in the ongoing evolution of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…